Wednesday, February 05, 2020 10:19:50 AM
A bit more color if you will, and only an opinion. It’s a consolidation issue. Hexo has a contract with Valens. The contract in dispute concerns the carry over from Newstrike purchase. Not saying the don’t have to honor it, just saying. Hexo is having product being returned to them / stuff that didn’t sell after 3mo comes back. This is happening all over.
Hexo has subtracted nearly $9 million from their gross revenue due to product returns and provisions for future product returns.
Overcapacity.
So, companies, not just Hexo are having product returned, they can’t sell enough of the product they get from Valens side and then Medif keeps sending the {Newstrike contract stuff as well}
So Hexo no doubt tries to renegotiate, Medif doesn’t want to cut its own throat so here we are.
The bigger picture is the stuff isn’t selling.
Hexo has subtracted nearly $9 million from their gross revenue due to product returns and provisions for future product returns.
Overcapacity.
So, companies, not just Hexo are having product returned, they can’t sell enough of the product they get from Valens side and then Medif keeps sending the {Newstrike contract stuff as well}
So Hexo no doubt tries to renegotiate, Medif doesn’t want to cut its own throat so here we are.
The bigger picture is the stuff isn’t selling.
Recent MEDIF News
- MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- International Medical Sales Surge 43% as GMP Certified Producer Hits Global Growth Phase • AllPennyStocks.com • 03/30/2026 05:47:31 PM
- MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue • GlobeNewswire Inc. • 03/30/2026 11:45:00 AM
- MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results • GlobeNewswire Inc. • 03/25/2026 11:05:48 PM
- MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO • GlobeNewswire Inc. • 01/19/2026 01:00:00 PM
- MediPharm Labs to Enter New Market with Costa Rica Supply Agreement • GlobeNewswire Inc. • 01/13/2026 01:00:00 PM
- Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience • GlobeNewswire Inc. • 12/19/2025 01:45:00 PM
- MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns • GlobeNewswire Inc. • 12/11/2025 01:30:00 AM
- MediPharm Labs Completes First Shipment to France • GlobeNewswire Inc. • 12/04/2025 01:40:00 PM
- MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law • GlobeNewswire Inc. • 11/14/2025 03:00:00 PM
- MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains • GlobeNewswire Inc. • 11/13/2025 01:00:00 PM
- MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/10/2025 11:00:00 PM
